Atara Biotherapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2014 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Atara Biotherapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2014 to Q2 2024.
  • Atara Biotherapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 6, 2024 was 4.92M shares, a 95.1% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 4.92M -96.2M -95.1% Aug 6, 2024 10-Q 2024-08-12
Q1 2024 119M +21.4M +21.8% Mar 20, 2024 10-K 2024-03-28
Q3 2023 102M +7.04M +7.42% Oct 27, 2023 10-Q 2023-11-01
Q2 2023 101M +6.74M +7.14% Aug 1, 2023 10-Q 2023-08-08
Q1 2023 98M +4.57M +4.89% May 1, 2023 10-Q 2023-05-08
Q4 2022 95.9M Jan 31, 2023 10-K 2023-02-08
Q3 2022 94.9M +6.46M +7.31% Nov 1, 2022 10-Q 2022-11-08
Q2 2022 94.4M +9.6M +11.3% Jul 29, 2022 10-Q 2022-08-08
Q1 2022 93.4M +9.33M +11.1% Apr 25, 2022 10-Q 2022-05-05
Q3 2021 88.4M +10.7M +13.8% Oct 29, 2021 10-Q 2021-11-04
Q2 2021 84.8M +10.4M +14.1% Jul 30, 2021 10-Q 2021-08-09
Q1 2021 84.1M +25.1M +42.6% Apr 26, 2021 10-Q 2021-05-04
Q3 2020 77.7M +23.6M +43.5% Oct 30, 2020 10-Q 2020-11-09
Q2 2020 74.3M +20.5M +38.2% Jul 31, 2020 10-Q 2020-08-05
Q1 2020 59M +12.6M +27.3% Apr 30, 2020 10-Q 2020-05-06
Q3 2019 54.2M +8.5M +18.6% Oct 31, 2019 10-Q 2019-11-07
Q2 2019 53.8M +8.42M +18.6% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 46.3M +2.37M +5.4% Apr 30, 2019 10-Q 2019-05-09
Q3 2018 45.6M +15.1M +49.2% Oct 31, 2018 10-Q 2018-11-06
Q2 2018 45.3M +14.8M +48.4% Jul 27, 2018 10-Q 2018-08-01
Q1 2018 43.9M +14.8M +51% Apr 30, 2018 10-Q 2018-05-08
Q3 2017 30.6M +1.74M +6.01% Oct 31, 2017 10-Q 2017-11-09
Q2 2017 30.6M +1.75M +6.07% Jul 31, 2017 10-Q 2017-08-07
Q1 2017 29.1M +365K +1.27% Apr 30, 2017 10-Q 2017-05-04
Q3 2016 28.9M +229K +0.8% Oct 31, 2016 10-Q 2016-11-04
Q2 2016 28.8M +298K +1.05% Jul 31, 2016 10-Q 2016-08-08
Q1 2016 28.7M +4.38M +18% Apr 29, 2016 10-Q 2016-05-06
Q3 2015 28.6M +8.42M +41.6% Oct 31, 2015 10-Q 2015-11-06
Q2 2015 28.5M Jul 31, 2015 10-Q 2015-08-07
Q1 2015 24.4M Apr 30, 2015 10-Q 2015-05-11
Q3 2014 20.2M Nov 7, 2014 10-Q 2014-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.